Literature DB >> 33130036

HDL and cancer - causality still needs to be confirmed? Update 2020.

Shiva Ganjali1, Maciej Banach2, Matteo Pirro3, Zlatko Fras4, Amirhossein Sahebkar5.   

Abstract

An inverse correlation between high-density lipoprotein cholesterol (HDL-C) and cancer risk has been shown by several epidemiological studies. Some studies have even suggested that HDL-C can be used as a prognostic marker in patients with certain types of cancer. However, whether reduced HDL-C level is a consequential or causal factor in the development and progression of cancer remains a controversial issue. In this review, we update and summarize recent advances that highlight the role of HDL and some of its components in prognosis, diagnosis and treatment of cancer.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Apolipoproteina; Cancer; High-density lipoprotein (HDL)

Mesh：

Substances：

Year:  2020        PMID： 33130036     DOI： 10.1016/j.semcancer.2020.10.007

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN： 1044-579X            Impact factor:   15.707


  12 in total

1.  PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021.

Authors:  Maciej Banach; Paweł Burchardt; Krzysztof Chlebus; Piotr Dobrowolski; Dariusz Dudek; Krzysztof Dyrbuś; Mariusz Gąsior; Piotr Jankowski; Jacek Jóźwiak; Longina Kłosiewicz-Latoszek; Irina Kowalska; Maciej Małecki; Aleksander Prejbisz; Michał Rakowski; Jacek Rysz; Bogdan Solnica; Dariusz Sitkiewicz; Grażyna Sygitowicz; Grażyna Sypniewska; Tomasz Tomasik; Adam Windak; Dorota Zozulińska-Ziółkiewicz; Barbara Cybulska
Journal:  Arch Med Sci       Date:  2021-11-08       Impact factor: 3.318

2.  High Density Lipoproteins: Is There a Comeback as a Therapeutic Target?

Authors:  Arnold von Eckardstein
Journal:  Handb Exp Pharmacol       Date:  2022

3.  5-Fluorouracil Treatment of CT26 Colon Cancer Is Compromised by Combined Therapy with IMMODIN.

Authors:  Vlasta Demeckova; Dagmar Mudronova; Sona Gancarcikova; Peter Kubatka; Karol Kajo; Monika Kassayova; Bianka Bojkova; Marian Adamkov; Peter Solár
Journal:  Int J Mol Sci       Date:  2022-06-07       Impact factor: 6.208

4.  The associations between serum high-density lipoprotein cholesterol levels and malignant behavior in pancreatic neuroendocrine neoplasms.

Authors:  Li Quan; Yongkang Liu; Wenjing Cui; Xinru Wang; Weixiao Zhang; Zhongqiu Wang; Chuangen Guo; Chao Lu; Feixiang Hu; Xiao Chen
Journal:  Lipids Health Dis       Date:  2022-07-16       Impact factor: 4.315

5.  The effect of metabolic syndrome on head and neck cancer incidence risk: a population-based prospective cohort study.

Authors:  Huaili Jiang; Lei Zhou; Qiangsheng He; Kanglun Jiang; Jinqiu Yuan; Xinsheng Huang
Journal:  Cancer Metab       Date:  2021-06-03

6.  Low high-density lipoprotein cholesterol levels are associated with malignant intraductal papillary mucinous neoplasms: A multicenter study.

Authors:  Cheng Wang; Tingting Lin; Xinru Wang; Zhicheng Yu; Xiaoling Zhuge; Wenjing Cui; Miaomiao Wang; Zhongqiu Wang; Chuangen Guo; Xiao Chen
Journal:  Lipids Health Dis       Date:  2021-08-28       Impact factor: 3.876

Review 7.  A New Look at Novel Cardiovascular Risk Biomarkers: The Role of Atherogenic Lipoproteins and Innovative Antidiabetic Therapies.

Authors:  Jelena Vekic; Aleksandra Zeljkovic; Khalid Al Rasadi; Mustafa Cesur; José Silva-Nunes; Anca Pantea Stoian; Manfredi Rizzo
Journal:  Metabolites       Date:  2022-01-24

8.  The association between serum lipid levels and histological type of breast cancer.

Authors:  Xinru Wang; Yajie Wang; Miaomiao Wang; Xin Chen; Wenjing Cui; Xiao Chen
Journal:  Eur J Med Res       Date:  2022-08-19       Impact factor: 4.981

9.  Synergism between the metabolic syndrome components and cancer incidence: results from a prospective nested case-control study based on the China Health and Retirement Longitudinal Study (CHARLS).

Authors:  Lin Li; Fang Meng; Dongkui Xu; Lingkai Xu; Junlan Qiu; Xiaochen Shu
Journal:  BMJ Open       Date:  2022-09-17       Impact factor: 3.006

Review 10.  Revealing the Role of High-Density Lipoprotein in Colorectal Cancer.

Authors:  Aleksandra Zeljkovic; Jelena Vekic; Marija Mihajlovic; Tamara Gojkovic; Sandra Vladimirov; Dejan Zeljkovic; Vesna Spasojevic-Kalimanovska; Bratislav Trifunovic
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.